Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations

Molecular Neurodegeneration

Volumn 3, Issue 1, 2008, Pages

  Maarouf, Chera L ^a   Daugs, Ian D ^a   Spina, Salvatore ^b,c   Vidal, Ruben ^b   Kokjohn, Tyler A ^a,d   Patton, R Lyle ^a   Kalback, Walter M ^a   Luehrs, Dean C ^a   Walker, Douglas G ^a   Castaño, Eduardo M ^e   Beach, Thomas G ^a   Ghetti, Bernardino ^b   Roher, Alex E ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF SIENA   (Italy)

^d MIDWESTERN UNIVERSITY   (United States)

^e FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57649165532     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-3-20     Document Type: Article

References (85)

1. A common enzyme connects notch signaling and Alzheimer's disease. R Kopan A Goate, Genes Dev 2000 14 2799 2806 10.1101/gad.836900 11090127
2. Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway. D Spasic A Tolia K Dillen V Baert B De Strooper S Vrijens W Annaert, J Biol Chem 2006 281 26569 26577 10.1074/jbc.M600592200 16846981
3. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. MS Wolfe W Xia BL Ostaszewski TS Diehl WT Kimberly DJ Selkoe, Nature 1999 398 513 517 10.1038/19077 10206644
4. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. WT Kimberly MJ LaVoie BL Ostaszewski W Ye MS Wolfe DJ Selkoe, Proc Natl Acad Sci USA 2003 100 6382 6387 12740439 10.1073/pnas.1037392100
5. The gamma-secretase complex: membrane-embedded proteolytic ensemble. MS Wolfe, Biochemistry 2006 45 7931 7939 10.1021/bi060799c 16800619
6. Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. SS Hebert L Serneels T Dejaegere K Horre M Dabrowski V Baert W Annaert D Hartmann B De Strooper, Neurobiol Dis 2004 17 260 272 10.1016/j.nbd.2004.08.002 15474363
7. Presenilin: running with scissors in the membrane. DJ Selkoe MS Wolfe, Cell 2007 131 215 221 10.1016/j.cell.2007.10.012 17956719
8. Presenilin diversifies its portfolio. AL Parks D Curtis, Trends Genet 2007 23 140 150 10.1016/j.tig.2007.01.008 17280736
9. Presenilin-1 regulates neuronal differentiation during neurogenesis. M Handler X Yang J Shen, Development 2000 127 2593 2606 10821758
10. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. M Nishimura G Yu G Levesque DM Zhang L Ruel F Chen P Milman E Holmes Y Liang T Kawarai E Jo A Supala E Rogaeva DM Xu C Janus L Levesque Q Bi M Duthie R Rozmahel K Mattila L Lannfelt D Westaway HT Mount J Woodgett PE Fraser P St George-Hyslop, Nat Med 1999 5 164 169 10.1038/5526 9930863
11. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Z Zhang H Hartmann VM Do D Abramowski C Sturchler-Pierrat M Staufenbiel B Sommer M van de Wetering H Clevers P Saftig B De Strooper X He BA Yankner, Nature 1998 395 698 702 10.1038/27208 9790190
12. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. A Weidemann S Eggert FB Reinhard M Vogel K Paliga G Baier CL Masters K Beyreuther G Evin, Biochemistry 2002 41 2825 2835 10.1021/bi015794o 11851430
13. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. JA Davis S Naruse H Chen C Eckman S Younkin DL Price DR Borchelt SS Sisodia PC Wong, Neuron 1998 20 603 609 10.1016/S0896-6273(00)80998-8 9539132
14. Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. S Kumar-Singh J Theuns B Van Broeck D Pirici K Vennekens E Corsmit M Cruts B Dermaut R Wang C Van Broeckhoven, Hum Mutat 2006 27 686 695 10.1002/humu.20336 16752394
15. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. DR Borchelt G Thinakaran CB Eckman MK Lee F Davenport T Ratovitsky CM Prada G Kim S Seekins D Yager HH Slunt R Wang M Seeger AI Levey SE Gandy NG Copeland NA Jenkins DL Price SG Younkin SS Sisodia, Neuron 1996 17 1005 1013 10.1016/S0896-6273(00)80230-5 8938131
16. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. K Duff C Eckman C Zehr X Yu CM Prada J Perez-tur M Hutton L Buee Y Harigaya D Yager D Morgan MN Gordon L Holcomb L Refolo B Zenk J Hardy S Younkin, Nature 1996 383 710 713 10.1038/383710a0 8878479
17. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. D Scheuner C Eckman M Jensen X Song M Citron N Suzuki TD Bird J Hardy M Hutton W Kukull E Larson E Levy-Lahad M Viitanen E Peskind P Poorkaj G Schellenberg R Tanzi W Wasco L Lannfelt D Selkoe S Younkin, Nat Med 1996 2 864 870 10.1038/nm0896-864 8705854
18. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. M Citron D Westaway W Xia G Carlson T Diehl G Levesque K Johnson-Wood M Lee P Seubert A Davis D Kholodenko R Motter R Sherrington B Perry H Yao R Strome I Lieberburg J Rommens S Kim D Schenk P Fraser HP St George DJ Selkoe, Nat Med 1997 3 67 72 10.1038/nm0197-67 8986743
19. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. W Xia J Zhang D Kholodenko M Citron MB Podlisny DB Teplow C Haass P Seubert EH Koo DJ Selkoe, J Biol Chem 1997 272 7977 7982 10.1074/jbc.272.12. 7977 9065468
20. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease. O Murayama T Tomita N Nihonmatsu M Murayama X Sun T Honda T Iwatsubo A Takashima, Neurosci Lett 1999 265 61 63 10.1016/S0304-3940(99)00187-1 10327206
21. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. H Houlden M Baker E McGowan P Lewis M Hutton R Crook NW Wood S Kumar-Singh J Geddes M Swash F Scaravilli JL Holton T Lashley T Tomita T Hashimoto A Verkkoniemi H Kalimo M Somer A Paetau JJ Martin C Van Broeckhoven T Golde J Hardy M Haltia T Revesz, Ann Neurol 2000 48 806 808
22. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. JL Jankowsky DJ Fadale J Anderson GM Xu V Gonzales NA Jenkins NG Copeland MK Lee LH Younkin SL Wagner SG Younkin DR Borchelt, Hum Mol Genet 2004 13 159 170 10.1093/hmg/ddh019 14645205
23. When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking point on the role of presenilin mutations in Alzheimer disease. MS Wolfe, EMBO Rep 2007 8 136 140 17268504 10.1038/sj.embor.7400896
24. FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta. J Shioi A Georgakopoulos P Mehta Z Kouchi CM Litterst L Baki NK Robakis, J Neurochem 2007 101 674 681 10.1111/j.1471-4159.2006.04391.x 17254019
25. Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. B De Strooper, EMBO Rep 2007 8 141 146 17268505 10.1038/sj.embor.7400897
26. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. Q Chen A Nakajima SH Choi X Xiong YP Tang, J Neurosci Res 2008 86 1615 1625 10.1002/jnr.21601 18189321
27. Analysis of the core components of Alzheimer paired helical filaments. A gas chromatography/mass spectrometry characterization of fatty acids, carbohydrates and long-chain bases. WJ Goux S Rodriguez DR Sparkman, FEBS Lett 1995 366 81 85 10.1016/0014-5793(95)00486-S 7789523
28. Characterization of the glycolipid associated with Alzheimer paired helical filaments. WJ Goux S Rodriguez DR Sparkman, J Neurochem 1996 67 723 733 8764601
29. A quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain. WJ Goux B Liu AM Shumburo S Parikh DR Sparkman, J Alzheimers Dis 2001 3 455 466 12214031
30. Immunogold labeling of Alzheimer paired helical filaments with ganglioside MAB A2B5. JR Clements AJ Beitz CR Emory WH Frey, Alzheimer Dis Assoc Disord 1990 4 35 42 10.1097/00002093-199040100-00004 2317336
31. Alzheimer's disease: paired helical filaments and cytomembranes. EG Gray M Paula-Barbosa A Roher, Neuropathol Appl Neurobiol 1987 13 91 110 10.1111/j.1365-2990.1987.tb00174.x 3614544
32. Tau interacts with Golgi membranes and mediates their association with microtubules. CA Farah S Perreault D Liazoghli M Desjardins A Anton M Lauzon J Paiement N Leclerc, Cell Motil Cytoskeleton 2006 63 710 724 10.1002/cm.20157 16960886
33. Cell and molecular biology of Notch. UM Fiuza AM Arias, J Endocrinol 2007 194 459 474 10.1677/JOE-07-0242 17761886
34. Notch signalling: a simple pathway becomes complex. SJ Bray, Nat Rev Mol Cell Biol 2006 7 678 689 10.1038/nrm2009 16921404
35. Notch signaling: control of cell communication and cell fate. EC Lai, Development 2004 131 965 973 10.1242/dev.01074 14973298
36. Notch signaling, gamma-secretase inhibitors, and cancer therapy. I Shih TL Wang, Cancer Res 2007 67 1879 1882 10.1158/0008-5472.CAN-06-3958 17332312
37. The effects of conformational heterogeneity on the binding of the Notch intracellular domain to effector proteins: a case of biologically tuned disorder. A Bertagna D Toptygin L Brand D Barrick, Biochem Soc Trans 2008 36 157 166 10.1042/BST0360157 18363556
38. Regulation of Notch signaling by dynamic changes in the precision of S3 cleavage of Notch-1. S Tagami M Okochi K Yanagida A Ikuta A Fukumori N Matsumoto Y Ishizuka-Katsura T Nakayama N Itoh J Jiang K Nishitomi K Kamino T Morihara R Hashimoto T Tanaka T Kudo S Chiba M Takeda, Mol Cell Biol 2008 28 165 176 17967888 10.1128/MCB.00863-07
39. HES and HERP families: multiple effectors of the Notch signaling pathway. T Iso L Kedes Y Hamamori, J Cell Physiol 2003 194 237 255 10.1002/jcp.10208 12548545
40. CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? A Martinez Arias V Zecchini K Brennan, Curr Opin Genet Dev 2002 12 524 533 10.1016/S0959-437X(02)00336-2 12200157
41. Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function. AS Yap WM Brieher M Pruschy BM Gumbiner, Curr Biol 1997 7 308 315 10.1016/S0960-9822(06)00154-0 9133345
42. Molecular and functional analysis of cadherin-based adherens junctions. AS Yap WM Brieher BM Gumbiner, Annu Rev Cell Dev Biol 1997 13 119 146 10.1146/annurev.cellbio.13.1.119 9442870
43. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. LD Derycke ME Bracke, Int J Dev Biol 2004 48 463 476 10.1387/ijdb.041793ld 15349821
44. N-cadherin signaling in synapse formation and neuronal physiology. JL Bruses, Mol Neurobiol 2006 33 237 252 10.1385/MN:33:3:237 16954598
45. The cadherin superfamily in neural development: diversity, function and interaction with other molecules. S Hirano ST Suzuki C Redies, Front Biosci 2003 8 d306 d355 10.2741/972 12456358
46. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. P Marambaud PH Wen A Dutt J Shioi A Takashima R Siman NK Robakis, Cell 2003 114 635 645 10.1016/j.cell.2003.08.008 13678586
47. Distribution of erb-B2, erb-B3, and erb-B4 in the developing avian nervous system. JR Francoeur PM Richardson RJ Dunn S Carbonetto, J Neurosci Res 1995 41 836 845 10.1002/jnr.490410614 7500385
48. ErbB-4: mechanism of action and biology. G Carpenter, Exp Cell Res 2003 284 66 77 10.1016/S0014-4827(02)00100-3 12648466
49. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities. GA Vidal A Naresh L Marrero FE Jones, J Biol Chem 2005 280 19777 19783 10.1074/jbc.M412457200 15746097
50. Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage. CY Ni H Yuan G Carpenter, J Biol Chem 2003 278 4561 4565 10.1074/jbc.M210504200 12454007
51. Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment. QC Cheng O Tikhomirov W Zhou G Carpenter, J Biol Chem 2003 278 38421 38427 10.1074/jbc.M302111200 12869563
52. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. HJ Lee KM Jung YZ Huang LB Bennett JS Lee L Mei TW Kim, J Biol Chem 2002 277 6318 6323 10.1074/jbc.M110371200 11741961
53. Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression. YW Zhang R Wang Q Liu H Zhang FF Liao H Xu, Proc Natl Acad Sci USA 2007 104 10613 10618 17556541 10.1073/pnas.0703903104
54. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. AR Chaudhury KM Gerecke JM Wyss DG Morgan MN Gordon SL Carroll, J Neuropathol Exp Neurol 2003 62 42 54 12528817
55. Neuregulins: functions, forms, and signaling strategies. DL Falls, Exp Cell Res 2003 284 14 30 10.1016/S0014-4827(02)00102-7 12648463
56. Neuregulin signaling via erbB receptor assemblies in the nervous system. S Murphy R Krainock M Tham, Mol Neurobiol 2002 25 67 77 10.1385/MN:25:1:067 11890458
57. The Sun Health Research Institute Brain Donation Program: Description and Experience, 1987-2007. TG Beach LI Sue DG Walker AE Roher L Lue L Vedders DJ Connor MN Sabbagh J Rogers, Cell Tissue Bank 2008 9 229 245 18347928 10.1007/s10561-008-9067-2
58. Beta-amyloid plaques: stages in life history or independent origin? RA Armstrong, Dement Geriatr Cogn Disord 1998 9 227 238 10.1159/000017051 9681645
59. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. L Miravalle M Calero M Takao AE Roher B Ghetti R Vidal, Biochemistry 2005 44 10810 10821 10.1021/bi0508237 16086583
60. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. CR Harrington J Louwagie R Rossau E Vanmechelen RH Perry EK Perry JH Xuereb M Roth CM Wischik, Am J Pathol 1994 145 1472 1484 7992850
61. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. JE Hixson DT Vernier, J Lipid Res 1990 31 545 548 2341813
62. Differential assembly of human tau isoforms in the presence of arachidonic acid. ME King TC Gamblin J Kuret LI Binder, J Neurochem 2000 74 1749 1757 10.1046/j.1471-4159.2000.0741749.x 10737634
63. Amyloid beta inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptor. K Uemura A Kuzuya N Aoyagi K Ando Y Shimozono H Ninomiya S Shimohama A Kinoshita, Neuroscience 2007 145 5 10 10.1016/j.neuroscience.2006.12.022 17257767
64. Activity-dependent regulation of beta-catenin via epsilon-cleavage of N-cadherin. K Uemura T Kihara A Kuzuya K Okawa T Nishimoto H Bito H Ninomiya H Sugimoto A Kinoshita S Shimohama, Biochem Biophys Res Commun 2006 345 951 958 10.1016/j.bbrc.2006.04.157 16707106
65. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. M Thompson S Lauderdale MJ Webster VZ Chong B McClintock R Saunders CS Weickert, Brain Res 2007 1139 95 109 10.1016/j.brainres.2006.11.047 17280647
66. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. VZ Chong M Thompson S Beltaifa MJ Webster AJ Law CS Weickert, Schizophr Res 2008 100 270 280 10.1016/j.schres.2007.12.474 18243664
67. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. AJ Larner M Doran, J Neurol 2006 253 139 158 10.1007/s00415-005-0019-5 16267640
68. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. AE Roher YM Kuo C Esh C Knebel N Weiss W Kalback DC Luehrs JL Childress TG Beach RO Weller TA Kokjohn, Mol Med 2003 9 112 122 12865947
69. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. W Kalback C Esh EM Castano A Rahman T Kokjohn DC Luehrs L Sue R Cisneros F Gerber C Richardson B Bohrmann DG Walker TG Beach AE Roher, Neurol Res 2004 26 525 539 10.1179/016164104225017668 15265270
70. A nucleated assembly mechanism of Alzheimer paired helical filaments. P Friedhoff M von Bergen EM Mandelkow P Davies E Mandelkow, Proc Natl Acad Sci USA 1998 95 15712 15717 9861035 10.1073/pnas.95.26.15712
71. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective. K Iqbal I Grundke-Iqbal, J Alzheimers Dis 2006 9 219 242 16914861
72. Tau protein, the paired helical filament and Alzheimer's disease. M Goedert A Klug RA Crowther, J Alzheimers Dis 2006 9 195 207 16914859
73. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. J Berger-Sweeney DL McPhie JA Arters J Greenan ML Oster-Granite RL Neve, Brain Res Mol Brain Res 1999 66 150 162 10.1016/S0169-328X(99)00014-5 10095087
74. Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains. DL McPhie RK Lee CB Eckman DH Olstein SP Durham D Yager SG Younkin RJ Wurtman RL Neve, J Biol Chem 1997 272 24743 24746 10.1074/jbc.272.40.24743 9312066
75. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. ML Oster-Granite DL McPhie J Greenan RL Neve, J Neurosci 1996 16 6732 6741 8824314
76. Transgenic mice expressing APP-C100 in the brain. RL Neve FM Boyce DL McPhie J Greenan ML Oster-Granite, Neurobiol Aging 1996 17 191 203 10.1016/0197-4580(95)02074-8 8744400
77. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. J Shen RJ Kelleher III, Proc Natl Acad Sci USA 2007 104 403 409 17197420 10.1073/pnas.0608332104
78. Presenilin-1 280Glu -Ala mutation alters C-terminal APP processing yielding longer Abeta peptides: Implications for Alzheimer's disease. GD Van Vickle CL Esh TA Kokjohn RL Patton WM Kalback DC Luehrs TG Beach AJ Newel F Lopera B Ghetti R Vidal EM Castano AE Roher, Mol Med 2008 14 184 194 18317569
79. Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein. T Sato N Dohmae Y Qi N Kakuda H Misonou R Mitsumori H Maruyama EH Koo C Haass K Takio M Morishima-Kawashima S Ishiura Y Ihara, J Biol Chem 2003 278 24294 24301 10.1074/jbc.M211161200 12707272
80. Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). A Kuzuya K Uemura N Kitagawa N Aoyagi T Kihara H Ninomiya S Ishiura R Takahashi S Shimohama, J Neurosci Res 2007 85 153 165 10.1002/jnr.21104 17075903
81. Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. P Marambaud NK Robakis, Genes Brain Behav 2005 4 134 146 10.1111/j.1601-183X.2005.00086.x 15810902
82. Protein trafficking and Alzheimer's disease. K Uemura A Kuzuya S Shimohama, Curr Alzheimer Res 2004 1 1 10 10.2174/1567205043480528 15975080
83. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. CA Saura SY Choi V Beglopoulos S Malkani D Zhang BS Shankaranarayana Rao S Chattarji RJ Kelleher III ER Kandel K Duff A Kirkwood J Shen, Neuron 2004 42 23 36 10.1016/S0896-6273(04)00182-5 15066262
84. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. SP Sardi J Murtie S Koirala BA Patten G Corfas, Cell 2006 127 185 197 10.1016/j.cell.2006.07.037 17018285
85. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. K Heininger, Rev Neurosci 2000 11 Spec No 213 328 11065271